← Back to Research & Discovery

Clinical & translational studies playbook

A practical playbook and checklist to plan validation, regulatory steps, and risk mitigation for translating discoveries into clinical studies.

Clinical & translational studies playbook

Plan the validation, regulatory pathway, and operational steps that reduce late-stage surprises and keep a discovery on track for clinical testing and early translation.

Why this playbook matters

Translation from bench to bedside is a sequence of predictable decisions and preventable traps: choosing the correct regulatory pathway, documenting preclinical evidence, designing studies that can answer regulatory and clinical questions, planning manufacturing and quality controls, and aligning partners and budgets. Missing or late decisions create delays, wasted effort, and lost opportunities. This playbook helps teams structure those decisions so they can be reviewed, assigned, and tracked early.

What you'll understand, practice, and accomplish

Using the included Clinical & Translational Validation Checklist you will be able to:

  • Map likely regulatory classifications and the evidence expected for first-in-human or feasibility studies.
  • Identify essential preclinical and reproducibility checks and decide which need additional experiments or independent validation.
  • Plan study design basics (primary questions, endpoints, sample-size considerations, monitoring needs) before engaging statisticians and clinical partners.
  • Document manufacturing, quality (GLP/GMP), and supply requirements that affect study timing and cost.
  • Create a risk register for regulatory, ethical, IP, commercial, and operational risks and assign owners and mitigation steps.

Who benefits — practical examples

Academic investigators preparing a translational grant can use the checklist to expose gaps in reproducibility and define additional validation experiments. A biotech startup can use it to align preclinical evidence, CMC planning, and investor due diligence. A hospital research office can standardize expectations for investigator‑initiated device or drug studies. Nonprofits and small manufacturers can use the playbook to scope partner needs and avoid costly late changes.

How this fits the Research & Discovery domain

This resource ties operational planning to reproducibility, IP strategy, partner selection, and commercialization planning. Think of the playbook as the bridge between discovery-focused work (experimental design, data quality, hypothesis development) and translation-focused execution (regulatory strategy, manufacturing readiness, clinical study planning).

Use the checklist and adapt it to your context

The checklist is a starting point you should tailor. On this platform you can copy the checklist into a team collection, convert it into an interactive form to capture responses, and evolve it as your project learns more. When planning critical regulatory submissions or complex clinical trials, pair checklist outputs with formal regulatory, clinical, and legal counsel.

Start with the Clinical & Translational Validation Checklist to document your assumptions, identify gaps, and create an owned plan you can review with clinical and regulatory experts.

Make useful resources part of something bigger.

The Hunger Engine is moving toward living domains, toolkits, and collections that people and organizations can explore, acquire, tailor, extend, and improve. A useful resource can become part of a personal collection, team toolbox, site-specific domain, or shared enterprise capability.

Start with what you're hungry to improve. As your needs grow, collections can bring together knowledge, audits, forms, dashboards, data, AI, integrations, and other capabilities without requiring you to start from scratch.